在急性心肌梗塞中评估IVUS引导的PCI:与血管学指导的比较元分析
Hongjuan Fang1, Ting Wang2, Lina Zhang3
1Department of Electronic Diagnosties, Jilin Province FAW General Hospital, Changchun, China.
Acta cardiologica
|August 6, 2025
概括
与标准血管造影相比,血管内超声 (IVUS) 引导的皮肤冠状动脉干预 (PCI) 显著降低了急性心肌梗塞 (AMI) 患者的死亡率和主要不良心脏事件. 这一元分析证实了IVUS的好处,并主张在AMI护理中更广泛地采用它.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 医疗成像医学成像
背景情况:
- 血管内超声 (IVUS) 指导在皮肤冠状动脉干预 (PCI) 中具有好处,但其对急性心肌梗塞 (AMI) 患者的具体影响尚不清楚.
- 这项研究解决了关于IVUS引导PCI在AMI的有效性方面的知识差距.
研究的目的:
- 系统地审查和元分析AMI患者的IVUS引导与血管学引导PCI的临床结果.
- 确定IVUS指导对AMI患者死亡率,主要心脏不良事件 (MACE),心脏死亡和目标血管再血管化 (TVR) 的影响.
主要方法:
- 在主要数据库 (PubMed,Cochrane Library,Embase,Web of Science,CNKI) 中进行了全面的文献搜索.
- 包括比较IVUS指导和血管学指导的AMI患者PCI的研究.
- 采用随机效应模型,将风险比率 (RRs) 和主要结果的95%置信区间 (CI) 结合起来.
主要成果:
- 分析了9项涉及838,902名患者的研究 (38,949名IVUS指导,796,953名血管学指导).
- 与血管学指导相比,IVUS引导的PCI显示出所有原因死亡率 (RR 0.74),MACE (RR 0.88),心脏死亡 (RR 0.67) 和TVR (RR 0.86) 的显著降低.
- 结果在敏感性分析中保持稳定,尽管观察到适度的异质性.
结论:
- 在AMI患者中,IVUS引导的PCI与改善的临床结果有关,包括降低死亡率和MACE.
- 这些发现支持使用IVUS指南来加强急性心肌梗塞后的患者护理.
- 建议进行进一步的研究,以确定和克服IVUS在临床实践中更广泛实施的障碍.
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
28
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
28
Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Acute Coronary Syndrome I: Introduction
73
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
73
Cardiac Catheterization I: Pre-Procedure Overview
156
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
156
Angina IV: Management
24
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
24
Cardiac Catheterization IV: Nursing Management
193
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
193


